US SB3449 | 2021-2022 | 117th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on January 10 2022 - 25% progression, died in committee
Action: 2022-01-10 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on January 10 2022 - 25% progression, died in committee
Action: 2022-01-10 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to require foreign establishments engaged in the manufacture, preparation, propagation, compounding, or processing of a drug or device to register with the Food and Drug Administration regardless of whether the drug or device undergoes further manufacture, preparation, propagation, compounding, or processing at a separate establishment outside the United States prior to being imported into the United States.
Title
Registration of Certain Foreign Establishments Act
Sponsors
Sen. Gary Peters [D-MI] | Sen. Susan Collins [R-ME] |
History
Date | Chamber | Action |
---|---|---|
2022-01-10 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Same As/Similar To
SB3799 (Related) 2022-03-15 - Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
Subjects
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/117th-congress/senate-bill/3449/all-info |
Text | https://www.congress.gov/117/bills/s3449/BILLS-117s3449is.pdf |